CREXENDO INC CXDO 深 滬
等待開盤 07-22 09:30:00 美东时间
5.66
-0.040
-0.70%
華盛通- 最 高5.79
- 今 開5.74
- 成交量 15.51万股
- 最 低 5.63
- 昨 收 5.70
- 總市值 1.64亿
- 52周最高 7.34
- 市盈率 靜 101.25
- 換手率 0.00%
- 52周最低 3.62
- 委 比 -25.95%
- 總股本 2903.05万
- 歷史最高 12.756
- 量 比 1.32
- 振 幅 2.81%
- 歷史最低 1.2399
- 每 手 1
- 風險率 0.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Crexendo's Open Strategy Pays Off, Analyst Praises 'Disruptive Pricing Model'
Crexendo's pre-packaged features have the "right balance of configuration" for both retail and wholesale customer wins, analysts say.
07-01 22:31
Crexendo Says BCN Makes Strategic Investment To Expand Capacity Of Its IP Voice Services
Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including
06-25 00:17
12 Information Technology Stocks Moving In Monday's After-Market Session
Gainers Credo Technology Group (NASDAQ:CRDO) stock rose 12.0% to $70.35 during...
06-03 05:05
美股大行评级 | 潜在涨幅105.34%！Amylyx Pharmaceuticals获Leerink Partners升目标价至10美元，上调至"跑赢大市"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
05-08 08:45
D. Boral Capital Maintains Buy on Crexendo, Maintains $10 Price Target
D. Boral Capital analyst Jesse Sobelson maintains Crexendo (NASDAQ:CXDO) with a Buy and maintains $10 price target.
05-07 19:18
12 Information Technology Stocks Moving In Friday's Intraday Session
Gainers D-Wave Quantum (NYSE:QBTS) shares rose 39.5% to $9.64 during Friday's ...
03-15 01:05
美股大行评级 | 摩根大通：维持Alignment Healthcare"中性"评级，目标价从14美元升至17美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104689832132448256.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Chardan Capital：维持Ocugen(OCGN)"买入"评级，目标价从6美元升至7美元</p> <p>• Piper Sandler：维持ALX Oncology Holdings(ALXO)"超配"评级，目标
03-07 13:53
美股大行评级 | 富国银行：维持艾伯维"超配"评级，目标价从210美元升至240美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104327819967434752.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持AnaptysBio(ANAB)"超配"评级，目标价从36美元升至42美元</p> <p>• 摩根大通
03-06 11:20
Crexendo Inc. Reports Record Growth and Profitability
Crexendo Inc. (($CXDO)) has held its Q4 earnings call. Read on for the main hig...
03-06 08:29
